[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2024-08-28 Disclosures
[Disclosure] Hanwha Ocean (042660) – Other Management Matters (Voluntary Disclosure) (Correction) / 2024-08-28 Disclosures
[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P13 SC (Zymfentra) in Europe (Part 1 & 2) (Rheumatoid Arthritis) / 2024-08-27 Disclosures
[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2024-08-26 Semiconductors
[Disclosure] Celltrion (068270) – Final Marketing Authorization Granted by European Commission (EC) for Steqeyma (CT-P43, Stelara Biosimilar) / 2024-08-26 Disclosures
[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in Europe (Part 1 & 2) / 2024-08-23 Disclosures
[Disclosure] Hanwha Aerospace (012450) – Trading Suspension and Resumption of Stock Futures and Options / 2024-08-22 Disclosures
![[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2024-08-28](https://kstockbriefing.com/wp-content/uploads/2026/07/포맷변환-한미반도체-1.jpg)
![[Disclosure] Hanwha Ocean (042660) – Other Management Matters (Voluntary Disclosure) (Correction) / 2024-08-28](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환한화오션.jpg)
![[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P13 SC (Zymfentra) in Europe (Part 1 & 2) (Rheumatoid Arthritis) / 2024-08-27](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환셀트리온.jpg)
![[Disclosure] Hanwha Aerospace (012450) – Trading Suspension and Resumption / 2024-08-22](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환-한화에어로스페이스.jpg)